How Agility is Transforming the Pharmaceutical Industry

The pharmaceutical industry is undergoing profound changes. Traditional working methods must adapt to a rapidly changing environment. According to the “Healthcare Outlook 2023” study by the Health Research Institute, the pharmaceutical industry is increasingly focusing on prevention rather than cure (Health Research Institute, 2023). This shift means that diseases should be avoided by placing the patient at the center.

Agile working methods are key to success, as they allow for quick adaptation to changes and early learning about what works and what doesn’t. An agile environment promotes quick adjustments and improves responsiveness to new challenges.

The pharmaceutical industry is increasingly focusing on preventive measures, placing the patient at the center. Previously, the doctor, the insurance company, or the product often took center stage. In the future, it will be crucial to work customer-centered to ensure long-term success. Employees must understand what the patient needs throughout their entire medical history. It’s about considering the whole person, not just selling a single product.

Many pharmaceutical companies have already started to reposition themselves to be closer to the patient. Doctors and hospitals are viewed as ecosystems in which the patient moves. This new structure requires comprehensive changes within companies. Large and globally operating companies are increasingly investing in preventive measures and developing new business models.

The “Future of Pharma 2023” study by McKinsey & Company also shows that companies that invest in preventive measures early are more successful in the long term (McKinsey & Company, 2023). The necessary changes significantly impact employee leadership and collaboration. Leaders must learn how to best support their teams in this new environment.